June 20, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — CombiMatrix Corp. (NASDAQ: CBMX) said that its laboratory services subsidiary, CombiMatrix Diagnostics, has received the final licensure documentation and approvals from Medicare allowing it to bill for its suite of array-based diagnostics tests.

Dr. Amit Kumar, CEO of CombiMatrix Corp, noted, "While this development will not significantly affect our developmental tests, we believe that certain barriers to the utilization of our cancer tests have now been eliminated."

As we continue our restructuring process, we are pleased to report on the progress of our parallel reimbursement activities which will drive the acceleration of our diagnostics commercialization efforts," concluded Dr. Kumar.

Dr. Mansoor Mohammed, CEO of CombiMatrix Diagnostics added, "This recent advancement provides us with a reimbursement environment that allows us to execute our oncology business strategy."

CombiMatrix Diagnostics offers its newly branded DNAarray portfolio of cancer-focused tests to oncologists, hospital-based pathologists and other commercial reference laboratories, through its Irvine, California, CLIA-certified, CAP-accredited laboratory.

Real-time streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate, courtesy of Stock Smart (at http://investrend.stocksmart.com/ss/html/hpcompany.html).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[frlylrf] [bsnnssb] [hlthcrdp] [ftrdnwswnd] [dvcmntnmc] [gvrnmnt]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.